Press releaseGlobe Newswire
Medicine Man Technologies
SHWZ · OTC
$0.00+$0.00 (+900.00%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseGlobe Newswire
Schwazze Reaches Agreement to Restructure its Balance Sheet and Portfolio of Assets
- NewsNicolás Jose Rodriguez
Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip
- NewsNicolás Jose Rodriguez
Ka-Ching! Schwazze's Cannabis Accounting Bloopers And Other Historic Missteps That Shook Up Big Business
- Press releaseGlobe Newswire
Schwazze Provides Update on Delayed Filings
- NewsNina Zdinjak
Schwazze's Q3 Preliminary Revenue Slides As Debt Grows, 2023 Financials Face Re-Audit
- Press releaseGlobe Newswire
Schwazze Announces Preliminary Third Quarter 2024 Financial Results
- NewsNicolás Jose Rodriguez
Is Colorado's Cannabis Market Back On Track? A 5% Sales Boost Says Yes
- NewsRolando García
Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025
- NewsNicolás Jose Rodriguez
Don't Let Hidden Debt Fool You: How Cannabis Investors Can Tell If They Are Safe
- NewsNina Zdinjak
Schwazze Q2 Revenue Up 2% YoY, Net Loss Rises And Debt Remains High
- Press releaseGlobe Newswire
Schwazze Announces Second Quarter 2024 Financial Results
- NewsJelena Martinovic
Cannabis Companies About To Release Earnings Reports, Get Your News Here: Glass House, Schwazze And More
- Press releaseGlobe Newswire
Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET
- NewsNicolás Jose Rodriguez
Cannabis Stocks React To Biden Announcement: Monday's Closing Market Moves
- NewsNicolás Jose Rodriguez
Cannabis Stocks Surge Then Plummet On News That Biden Is Bowing Out Of 2024 Presidential Race
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.